BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 10, 2026
Breaking News: Regeneration in mammals is controlled by environmental conditionsBreaking News: Best of BioWorld Science: Q1
Home » Topics » BioWorld

BioWorld
BioWorld RSS Feed RSS

Conference data for Feb. 11, 2021: ASCO GU

Feb. 11, 2021
New and updated preclinical and clinical data presented by biopharma firms at the American Society of Clinical Oncology Genitourinary Cancers Symposium, including: Aveo, Cardiff, Clovis, Essa, Infinity, Noxopharm.
Read More
Regulatory front

NIH, trade groups: More inclusive vaccine research urgently needed

Feb. 11, 2021
By Mari Serebrov
The latest global regulatory news, changes and updates affecting biopharma, including: Fed Circuit agrees Amgen patents lack enablement; HC nudging along with regulatory modernization plan; EMA: No Sputnik application yet.
Read More

Regulatory actions for Feb. 11, 2021

Feb. 11, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Clinuvel, Genmab, Moderna, Oryzon, Polaryx, Seagen.
Read More

Other news to note for Feb. 11, 2021

Feb. 11, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atyr, Celltrion, China SXT, Dnatrix, Dyno, Exscientia, Gain, GSK, Incyte, M6P, Macrogenics, Mindmed, Mindshift, Nuvation, Olix, Panacea, Portage, Protalix, Renji, Rentschler, Repertoire, Sandoz, Sarcomed, Vyne.
Read More

In the clinic for Feb. 11, 2021

Feb. 11, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Acer, Actinium, Almirall, Artios, Athenex, Benevolentai, Kite, Mesoblast, Olatec, Outlook, Urovant.
Read More

Financings for Feb. 11, 2021

Feb. 11, 2021
Biopharmas raising money in public or private financings, including: Adagene, Allarity, Applied Therapeutics, Athira, Biondvax, Cyteir, FSD, GT Biopharma, Iterum, Kadmon, Kalvista, Medincell, Moleculin, Neximmune, Ocugen, Predictive Oncology, Pulmatrix.
Read More

Appointments and advancements for Feb. 11, 2021

Feb. 11, 2021
New hires and promotions in the biopharma industry, including: Antios, Biodelivery Sciences, Contrafect, Kromatid, Recro, Retrotope, Sophia Genetics, Surface Oncology, Tryp.
Read More

Earnings for Feb. 11, 2021

Feb. 11, 2021
Quarterly snapshots from biopharma companies with marketed products, including: Alkermes, Alnylam, Exelixis, Karyopharm, Vanda.
Read More
Human NK cell
Bench Press

HIV-infected macrophages evade NK cells

Feb. 11, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: iPSCs give sneak preview of AML.
Read More

Other news to note for Feb. 9, 2021

Feb. 11, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adnab, Aerami, Algernon, Alterity, Antibe, Apollomics, Applied Biomath, Arch, Area, Azurrx, Basilea, Bostongene, Camargo, Cellular Biomedicine, Chance, Charles River, Compass Pathways, Edison, Eikonizo, Eloxx, Evotec, Freeline, Hengrui, Herantis, Homology, Hoth, Jemincare, Jubilant, Lannett, Lassen, Merck & Co., Nanoform, Nuance, Otsuka, Pfizer, PPD, Respirerx, Revitope, Sigilon, Sorrento, Stemedix, Synaptogenix, Taysha, Tmunity, Tryp, Yingli.
Read More
Previous 1 2 … 1678 1679 1680 1681 1682 1683 1684 1685 1686 … 9059 9060 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 9, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • Connecting puzzle pieces

    Korsana boosts Alzheimer’s work with reverse merger, $380M financing

    BioWorld Science
    Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing